Form 4 for ASND Ascendis Pharma A/S
Accepted 2026-06-01 16:10:28 ET · period of report 2026-05-29 · accession 0001610717-26-000176 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-01 16:10 | 2026-05-29 | ASND | SMITH SCOTT THOMAS | EVP, CFO | P - Purchase | $223.32 | +250 | 4,267 | +6% | +$55.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-05-29 | P | A | 250 | $223.32 | 4,267 | D | — | — |